Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACADIA HEALTHCARE COMPANY, INC.

(ACHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Acadia Healthcare : Names New Chief Development Officer

10/11/2021 | 02:41pm EST


ę MT Newswires 2021
All news about ACADIA HEALTHCARE COMPANY, INC.
12/01Acadia Healthcare to Manage Behavioral Health Program for Orlando Health
MT
12/01Acadia Healthcare Forms Joint Venture With Orlando Health
BU
12/01Orlando Health Forms Joint Venture With Acadia Healthcare to Expand Behavioral Health S..
BU
11/17Bronson Healthcare and Acadia Healthcare Break Ground on New Behavioral Health Hospital..
BU
11/11Eastlake Behavioral Health Hospital Approved by Chula Vista Planning Commission
BU
10/29ACADIA HEALTHCARE COMPANY, INC. Management's Discussion and Analysis of Financial Cond..
AQ
10/29Health Care Stocks Rising Ahead of Friday Close
MT
10/29Health Care Stocks Extending Friday's Gains
MT
10/29Acadia Healthcare Company Seeks Acquisitions
CI
10/28Acadia Healthcare Posts Higher Q3 Results, Tightens Guidance -- Stock Up Near 3% After-..
MT
More news
Analyst Recommendations on ACADIA HEALTHCARE COMPANY, INC.
More recommendations
Financials (USD)
Sales 2021 2 309 M - -
Net income 2021 191 M - -
Net Debt 2021 1 247 M - -
P/E ratio 2021 26,7x
Yield 2021 -
Capitalization 4 835 M 4 835 M -
EV / Sales 2021 2,63x
EV / Sales 2022 2,43x
Nbr of Employees 35 400
Free-Float 98,7%
Chart ACADIA HEALTHCARE COMPANY, INC.
Duration : Period :
Acadia Healthcare Company, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACADIA HEALTHCARE COMPANY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 53,76 $
Average target price 75,14 $
Spread / Average Target 39,8%
EPS Revisions
Managers and Directors
Debra Kay Osteen Chief Executive Officer & Director
David M. Duckworth Chief Financial Officer
Reeve Byron Waud Chairman
Michael V. Genovese Chief Medical Officer
John S. Hollinsworth Executive Vice President-Operations